A Phase I/Ii Study of Rituximab and Etanercept in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

Leukemia - United Kingdom
doi 10.1038/leu.2008.385
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC